Rudy Li
Stock Analyst at Wolfe Research
(4.91)
# 228
Out of 5,043 analysts
80
Total ratings
59.4%
Success rate
72.6%
Average return
Main Sectors:
Stocks Rated by Rudy Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HRMY Harmony Biosciences Holdings | Initiated Coverage: Buy | $60 | $40.28 | +48.96% | 1 | Aug 26, 2026 | |
| IMUX Immunic | Reiterated: Buy | $30 → $25 | $8.19 | +205.25% | 3 | Aug 11, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | $40 | $24.74 | +61.68% | 20 | Aug 3, 2026 | |
| QURE uniQure | Upgraded: Buy | $65 | $22.59 | +187.74% | 2 | Jul 29, 2026 | |
| CMPS COMPASS Pathways | Reiterated: Buy | $18 | $12.00 | +50.00% | 1 | Jul 7, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $45 | $37.22 | +20.90% | 1 | Jul 7, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Hold | n/a | $18.15 | - | 1 | Jul 7, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $33 | $19.78 | +66.84% | 2 | May 6, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $160 | $142.44 | +12.33% | 2 | Apr 6, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $500 | $259.86 | +92.41% | 7 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $40.61 | +10.81% | 2 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $168.35 | +36.62% | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 → $25 | $36.90 | -32.25% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $19.45 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 → $60 | $36.44 | +64.65% | 5 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $8.84 | +103.62% | 15 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $24.37 | -38.45% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $40 | $0.50 | n/a | 1 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $54.05 | n/a | 2 | May 21, 2025 |
Harmony Biosciences Holdings
Aug 26, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $40.28
Upside: +48.96%
Immunic
Aug 11, 2026
Reiterated: Buy
Price Target: $30 → $25
Current: $8.19
Upside: +205.25%
Stoke Therapeutics
Aug 3, 2026
Reiterated: Buy
Price Target: $40
Current: $24.74
Upside: +61.68%
uniQure
Jul 29, 2026
Upgraded: Buy
Price Target: $65
Current: $22.59
Upside: +187.74%
COMPASS Pathways
Jul 7, 2026
Reiterated: Buy
Price Target: $18
Current: $12.00
Upside: +50.00%
LB Pharmaceuticals
Jul 7, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $37.22
Upside: +20.90%
Seaport Therapeutics
Jul 7, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $18.15
Upside: -
Acadia Pharmaceuticals
May 6, 2026
Reiterated: Buy
Price Target: $33
Current: $19.78
Upside: +66.84%
Neurocrine Biosciences
Apr 6, 2026
Reiterated: Buy
Price Target: $160
Current: $142.44
Upside: +12.33%
Praxis Precision Medicines
Apr 6, 2026
Reiterated: Buy
Price Target: $500
Current: $259.86
Upside: +92.41%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $40.61
Upside: +10.81%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $230
Current: $168.35
Upside: +36.62%
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $20 → $25
Current: $36.90
Upside: -32.25%
Feb 23, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $19.45
Upside: -
Feb 23, 2026
Initiated Coverage: Buy
Price Target: $55 → $60
Current: $36.44
Upside: +64.65%
Dec 31, 2025
Initiated Coverage: Buy
Price Target: $18
Current: $8.84
Upside: +103.62%
Oct 20, 2025
Reiterated: Buy
Price Target: $15
Current: $24.37
Upside: -38.45%
Sep 29, 2025
Initiated Coverage: Buy
Price Target: $40
Current: $0.50
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $80
Current: $54.05
Upside: n/a